Xcellerex:Guy Broadbent President and CEO
Article continues below
Mr. Broadbent succeeds Joseph Zakrzewski, who served as Chairman, President and CEO, as part of an existing management succession process planned as the company begins its next phase in commercializing its novel single-use biomanufacturing technology, proprietary services and biomolecules businesses. Mr. Zakrzewski will remain on the Board of Directors as Chairman. ■